Proglumetacin
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoate |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Hepatic. Undergoes enterohepatic recirculation |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C46H58ClN5O8 |
| Molar mass | 844.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Proglumetacin (usually as the maleate salt, trade names Afloxan, Protaxon and Proxil) is a nonsteroidal anti-inflammatory drug (NSAID). It is metabolized in the body to indometacin and proglumide, a drug with antisecretory effects that helps prevent injury to the stomach lining.
|
pyrazolones / pyrazolidines |
|
|---|---|
| salicylates | |
|
acetic acid derivatives and related substances |
|
| oxicams | |
|
propionic acid derivatives (profens) |
|
|
n-arylanthranilic acids (fenamates) |
|
|
COX-2 inhibitors (coxibs) |
|
| other | |
| NSAID combinations |
|
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |